高脂血症在肾病患者中的重要性及治疗 - Suppr

Suppr

超能文献

Importance of hyperlipidaemia and therapy in renal patients.

作者信息

Wanner C

机构信息

Department of Medicine, Division of Nephrology, University of Würzburg, Germany.

出版信息

Nephrol Dial Transplant. 2000;15 Suppl 5:92-6. doi: 10.1093/ndt/15.suppl_5.92.

DOI:10.1093/ndt/15.suppl_5.92

PMID:11073280

Abstract

摘要

相似文献

Importance of hyperlipidaemia and therapy in renal patients.

Nephrol Dial Transplant. 2000;15 Suppl 5:92-6. doi: 10.1093/ndt/15.suppl_5.92.

Hyperlipidemia in atherosclerosis. Dietary and drug treatment.

Med Clin North Am. 1970 May;54(3):657-69.

[Hyperlipidemia complicated with hypertension].

Nihon Rinsho. 2001 Mar;59 Suppl 3:738-42.

Should hyperlipidaemia in dialysis patients be treated?

Nephrol Dial Transplant. 1997 Jan;12(1):19-21. doi: 10.1093/ndt/12.1.19.

Regression of computer estimated femoral atherosclerosis after pronounced serum lipid lowering in patients with asymptomatic hyperlipidaemia.

Lancet. 1982 Jun 5;1(8284):1311. doi: 10.1016/s0140-6736(82)92881-1.

Lipids and Renal Disease.

Methodist Debakey Cardiovasc J. 2019 Jan-Mar;15(1):88-89. doi: 10.14797/mdcj-15-1-88.

Atherosclerotic disease in non-insulin-dependent diabetes mellitus: role of abnormal lipids and the place for lipid-altering therapies.

Am Heart J. 1999 Nov;138(5 Pt 1):S406-12. doi: 10.1016/s0002-8703(99)70043-8.

Management of hyperlipidaemia. Why, when and how to treat.

Eur Heart J. 1997 Mar;18(3):371-5. doi: 10.1093/oxfordjournals.eurheartj.a015257.

[Hyperlipidemia in patients with ischemic heart disease].

Nihon Rinsho. 2001 Mar;59 Suppl 3:722-7.

[Lipid distress syndrome in atherosclerosis obliterans].

Vestn Ross Akad Med Nauk. 1999(9):28-31.

引用本文的文献

Cardiovascular risk is similar in patients with glomerulonephritis compared to other types of chronic kidney disease: a matched cohort study.

BMC Nephrol. 2017 Mar 20;18(1):95. doi: 10.1186/s12882-017-0511-z.

Serum lipid profiles, lipid ratios and Chronic Kidney Disease in a Chinese population.

Int J Environ Res Public Health. 2014 Jul 29;11(8):7622-35. doi: 10.3390/ijerph110807622.

Assessment of dyslipidemia in pre-dialysis patients in south-west Nigeria.

Niger Med J. 2014 May;55(3):214-9. doi: 10.4103/0300-1652.132043.

Effects of hemodialysis on serum lipids and phospholipids of end-stage renal failure patients.

Mol Cell Biochem. 2004 Oct;265(1-2):57-61. doi: 10.1023/b:mcbi.0000044315.74038.78.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Importance of hyperlipidaemia and therapy in renal patients.

作者信息

Wanner C

机构信息

Department of Medicine, Division of Nephrology, University of Würzburg, Germany.

出版信息

Nephrol Dial Transplant. 2000;15 Suppl 5:92-6. doi: 10.1093/ndt/15.suppl_5.92.

DOI:10.1093/ndt/15.suppl_5.92

PMID:11073280

Abstract

摘要

相似文献

Importance of hyperlipidaemia and therapy in renal patients.

Nephrol Dial Transplant. 2000;15 Suppl 5:92-6. doi: 10.1093/ndt/15.suppl_5.92.

Hyperlipidemia in atherosclerosis. Dietary and drug treatment.

Med Clin North Am. 1970 May;54(3):657-69.

[Hyperlipidemia complicated with hypertension].

Nihon Rinsho. 2001 Mar;59 Suppl 3:738-42.

Should hyperlipidaemia in dialysis patients be treated?

Nephrol Dial Transplant. 1997 Jan;12(1):19-21. doi: 10.1093/ndt/12.1.19.

Regression of computer estimated femoral atherosclerosis after pronounced serum lipid lowering in patients with asymptomatic hyperlipidaemia.

Lancet. 1982 Jun 5;1(8284):1311. doi: 10.1016/s0140-6736(82)92881-1.

Lipids and Renal Disease.

Methodist Debakey Cardiovasc J. 2019 Jan-Mar;15(1):88-89. doi: 10.14797/mdcj-15-1-88.

Atherosclerotic disease in non-insulin-dependent diabetes mellitus: role of abnormal lipids and the place for lipid-altering therapies.

Am Heart J. 1999 Nov;138(5 Pt 1):S406-12. doi: 10.1016/s0002-8703(99)70043-8.

Management of hyperlipidaemia. Why, when and how to treat.

Eur Heart J. 1997 Mar;18(3):371-5. doi: 10.1093/oxfordjournals.eurheartj.a015257.

[Hyperlipidemia in patients with ischemic heart disease].

Nihon Rinsho. 2001 Mar;59 Suppl 3:722-7.

[Lipid distress syndrome in atherosclerosis obliterans].

Vestn Ross Akad Med Nauk. 1999(9):28-31.

引用本文的文献

Cardiovascular risk is similar in patients with glomerulonephritis compared to other types of chronic kidney disease: a matched cohort study.

BMC Nephrol. 2017 Mar 20;18(1):95. doi: 10.1186/s12882-017-0511-z.

Serum lipid profiles, lipid ratios and Chronic Kidney Disease in a Chinese population.

Int J Environ Res Public Health. 2014 Jul 29;11(8):7622-35. doi: 10.3390/ijerph110807622.

Assessment of dyslipidemia in pre-dialysis patients in south-west Nigeria.

Niger Med J. 2014 May;55(3):214-9. doi: 10.4103/0300-1652.132043.

Effects of hemodialysis on serum lipids and phospholipids of end-stage renal failure patients.

Mol Cell Biochem. 2004 Oct;265(1-2):57-61. doi: 10.1023/b:mcbi.0000044315.74038.78.